🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase 3 study is designed to demonstrate the safety and immunogenicity...
Status
Completed
Location
37 Alabama Clinical Therapeutics LLC 52 Medical Park East Drive Suite 203
Start Date
2009-11
Trial ID
NCT01000311
Treatments Being Tested
Safety and immunogenicity of meningococcal ACWY conjugate versus polysaccha...
Status
Completed
Location
FUNCEI, French 3085
Start Date
2006-05
Trial ID
NCT00329849
Treatments Being Tested
MenACWY (Menveo) is a GSK vaccine intended for protection against disease c...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-08-30
Trial ID
NCT03433482
Treatments Being Tested
This study is aimed to assess whether the frequency of meningococcal serogr...
Status
Completed
Location
Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine
Start Date
2007-07
Trial ID
NCT00488683
Treatments Being Tested
The goal of this clinical trial is to determine the immunogenicity of certa...
Status
Recruiting
Location
Emory Children's Center-Vaccine Research Clinic
Start Date
2025-11-04
Trial ID
NCT07197762
This study will evaluate safety, tolerability, and immunogenicity of a boos...
Status
Completed
Location
CESFAM Gabriela Mistral:
Start Date
2011-07
Trial ID
NCT01367158
MenACWY (Menveo) is a GSK vaccine intended for protection against disease c...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-09-07
Trial ID
NCT03652610
The purpose of this study is to evaluate the immunogenicity, safety and tol...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-25
Trial ID
NCT04318548